2647The Ohio State University College of Nursing, Columbus, OH, USA.
School of Nursing and Health Studies, 12273University of Missouri-Kansas City, Kansas City, MO, USA.
Prog Transplant. 2020 Dec;30(4):306-314. doi: 10.1177/1526924820958148. Epub 2020 Sep 10.
Cardiovascular disease is the leading cause of death in kidney transplant recipients. Physical activity after transplant is the most modifiable nonpharmacological factor for improving cardiovascular outcomes. Few studies have tested walking interventions to enhance daily steps and health outcomes in older kidney recipients.
Using a pilot feasibility randomized clinical trial design, we tested the feasibility and efficacy of a 6-month SystemCHANGE™ (Change Habits by Applying New Goals and Experience) + Activity Tracker intervention for recruitment, retention, daily steps, and health outcomes (blood pressure, heart rate, body mass index, waist circumference, and physical function). The SystemCHANGE™ + Activity Tracker intervention taught participants to use a multicomponent intervention that connects person-centered systems solutions combined with visual feedback from a mobile activity tracker to achieve daily step goals.
Fifty-three participants (mean age 65 years, 66% male, and 57% white) participated with 27 in the intervention and 26 in the control group. The study protocol was feasible to deliver with high adherence to the protocol in both groups. The intervention group increased daily steps at 3 months (mean difference, 608; standard error = 283, = .03) compared to the control group. The secondary outcome of heart rate decreased for the intervention group (baseline [mean] 74.4+ 10.8 [standard deviation, SD;] vs 6 months [mean] 67.6+ 11.3 [SD]; = .002) compared to the control group (baseline [mean] 70.67+ 10.4 [SD]; vs 6 months [mean] 70.2 + 11.1 [SD]; = .83).
SystemCHANGE™ + Activity Tracker intervention appears to be feasible and efficacious for increasing daily steps in older kidney recipients.
心血管疾病是肾移植受者的主要死亡原因。移植后进行身体活动是改善心血管结局的最可改变的非药物因素。很少有研究测试过步行干预措施,以增加老年肾移植受者的日常步数和健康结果。
我们采用试点可行性随机临床试验设计,测试了 6 个月的 SystemCHANGE™(通过应用新目标和体验改变习惯)+活动追踪器干预措施在招募、保留、日常步数和健康结果(血压、心率、体重指数、腰围和身体功能)方面的可行性和效果。SystemCHANGE™+活动追踪器干预措施教导参与者使用一种多组件干预措施,该措施将以患者为中心的系统解决方案与移动活动追踪器的视觉反馈相结合,以实现日常步数目标。
53 名参与者(平均年龄 65 岁,66%为男性,57%为白人)参与了研究,其中 27 名参与者接受了干预,26 名参与者接受了对照组。研究方案具有可操作性,两组均高度遵守方案。与对照组相比,干预组在 3 个月时的日常步数增加(平均差异,608;标准误差=283, =.03)。与对照组相比,干预组的心率作为次要结果下降(基线[平均值]74.4+10.8[标准差,SD] vs 6 个月[平均值]67.6+11.3[SD]; =.002)。
SystemCHANGE™+活动追踪器干预措施似乎可行且有效,可增加老年肾移植受者的日常步数。